系统性TNF抑制对炎症性关节炎餐后血糖调节激素的影响
基础胰岛素抵抗指数无显著变化,但GIP、胰淀素和PP血清基础水平在12、24和52周显著升高,校正CRP后结果一致。该效应对不同TNFi类型和诊断一致,PP与关节炎类型存在显著交互作用。
要点
- TNFi治疗52周内RA、PsA、axSpA患者基础胰岛素抵抗指数无显著变化。
- GIP、胰淀素和PP血清基础水平在TNFi治疗12、24和52周显著升高,校正CRP后一致。
- PP与关节炎类型存在显著交互作用,其余激素效应在不同TNFi类型和诊断间一致。
核心结论
- 启动TNFi治疗的患者中,GIP、胰淀素和PP血清水平升高,且不依赖于全身炎症。
- 该餐后血糖调节激素效应可能部分解释TNFi在风湿炎症性疾病中的心血管获益。
研究设计与样本
- 评估疾病活动度、急性期反应物、空腹血糖、胰岛素和C肽、HOMA2评估的胰岛素抵抗及血脂谱。
- 每次访视测量血清胰淀素、GIP和PP浓度,采用多变量线性混合效应模型分析临床和生化变量的时间变化。
主要发现
- RA、PsA或axSpA患者基础胰岛素抵抗指数在整个研究期间无显著变化。
- 单变量模型中GIP、胰淀素和PP血清基础水平显著升高,校正CRP后12、24和52周结果仍一致。
- 上述效应在不同TNFi类型和诊断间一致且特异,但PP与关节炎类型存在显著交互作用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The effects of systemic tumour necrosis factor (TNF) inhibition on glucose homeostasis are not fully understood. This study aims to evaluate the effects of TNF inhibitors (TNFis) on gastric inhibitory polypeptide (GIP), amylin and pancreatic polypeptide (PP), hormones involved in the fine-tuning of postprandial glucose homeostasis, in patients with RA, PsA and axial spondylarthritis (axSpA). METHODS: Sixty-four non-diabetic patients (RA, n = 22; PsA, n = 13; axSpA, n = 29) undergoing TNFi therapy were prospectively evaluated at baseline and after 12, 24 and 52 weeks. Assessments included measurements of disease activity, acute-phase reactants, fasting glucose, insulin and C-peptide levels, insulin resistance as assessed by the updated Homeostatic Model Assessment (HOMA)2 and lipid profile. Serum concentrations of amylin, GIP and PP were measured at each visit. Multivariable linear mixed-effects models were used to analyse temporal changes in clinical and biochemical variables. RESULTS: Basal insulin resistance indices did not significantly change throughout the study in patients with RA, PsA or axSpA. However, serum basal levels of GIP, amylin and PP significantly increased in the univariable model, and the results remained consistent after adjusting for CRP, at 12, 24 and 52 weeks of TNFi therapy. These effects were consistent and specific across different TNFi types and diagnoses, except for PP, which exhibited a significant interaction with the type of arthritis. CONCLUSIONS: In patients initiating TNFi therapy, serum levels of GIP, amylin and PP increase regardless of systemic inflammation. This effect on postprandial glucose-regulating hormones may help explain the cardiovascular benefits of TNFi in rheumatic inflammatory diseases, at least in part.
引用
- Ferraz-Amaro I, Hernández-Díaz M, García-Hernández JC, et al. Effects of systemic TNF inhibition on postprandial glucose-regulatory hormones in inflammatory arthritis. Rheumatology (Oxford). 2026. PMID: 41247104. doi:10.1093/rheumatology/keaf601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。